<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.eurjchem.com/lib/pkp/xml/oai2.xsl" ?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/
		http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
	<responseDate>2026-05-25T00:52:10Z</responseDate>
	<request identifier="oai:ojs.www.eurjchem.com:article/938" metadataPrefix="oai_dc" verb="GetRecord">https://www.eurjchem.com/index.php/eurjchem/oai</request>
	<GetRecord>
		<record>
			<header>
				<identifier>oai:ojs.www.eurjchem.com:article/938</identifier>
				<datestamp>2014-03-31T01:48:51Z</datestamp>
				<setSpec>eurjchem:ART</setSpec>
				<setSpec>driver</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">IL-17 level in patients with acute myocardial infarction and  its effect on lipid profile</dc:title>
	<dc:creator>Ibrahim, Ammal Esmaeel</dc:creator>
	<dc:creator>Hasan, Hiba Ali</dc:creator>
	<dc:creator>Jawad, Alaa Hussein</dc:creator>
	<dc:subject xml:lang="en-US">IL-17</dc:subject>
	<dc:subject xml:lang="en-US">Triglycerides</dc:subject>
	<dc:subject xml:lang="en-US">Total cholesterol</dc:subject>
	<dc:subject xml:lang="en-US">Low density lipoprotein</dc:subject>
	<dc:subject xml:lang="en-US">High density lipoprotein</dc:subject>
	<dc:subject xml:lang="en-US">Acute myocardial infarction</dc:subject>
	<dc:description xml:lang="en-US">Myocardial infarction (MI) is considered as the major cause of death and disability worldwide, and despite considerable advances in diagnosis and treatment, continues to be a major public health problem. Interleukin-17 (IL-17) is leukocyte-derived cytokine with effects especially on epithelial cells in various tissues. This study designed to investigate the level of IL-17 and its effect on lipid profile in patients with Acute Myocardial Infarction. The study included 50 patients with acute myocardial infarction forty healthy subjects as control group. The levels of IL-17 were significantly elevated in all patients groups (p &amp;lt; 0.001), total cholesterol, LDL, VLDL were significantly elevated (p &amp;lt; 0.001) in all patients as well.  There was positive correlation between IL-17 with HDL, while there was negative correlation with total cholesterol and LDL. The results show significant increase in levels of IL-17, in acute myocardial infarction patients. IL-17 positively correlated with HDL and negatively correlated with total cholesterol and LDL, which lead to consider it as cardio protective factor.</dc:description>
	<dc:publisher xml:lang="en-US">Atlanta Publishing House LLC</dc:publisher>
	<dc:date>2014-03-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://www.eurjchem.com/index.php/eurjchem/article/view/938</dc:identifier>
	<dc:identifier>10.5155/eurjchem.5.1.186-188.938</dc:identifier>
	<dc:source xml:lang="en-US">European Journal of Chemistry; Vol. 5 No. 1 (2014): March 2014; 186-188</dc:source>
	<dc:source>2153-2257</dc:source>
	<dc:source>2153-2249</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://www.eurjchem.com/index.php/eurjchem/article/view/938/PDF_938</dc:relation>
</oai_dc:dc>
			</metadata>
		</record>
	</GetRecord>
</OAI-PMH>
